1199 West Hastings Street
Suite 800
Vancouver, BC V6E 3T5
Canada
888-452-6731
https://core1labs.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Joel Shacker | CEO & Director | 177.61k | N/A | 1991 |
Mr. Geoffrey Balderson | CFO, Secretary & Director | 29.94k | N/A | 1978 |
Dr. Santiago Ferro | Chief Medical Officer & Director | 73.17k | N/A | N/A |
Mr. Brad Paul Eckenweiler | Founder & Advisor | N/A | N/A | 1954 |
Mr. Jan Burian Ph.D. | Chief Technical Officer | N/A | N/A | N/A |
Dr. Elizabeth Matthews | Head of Scientific & Regulatory Affairs | N/A | N/A | N/A |
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Core One Labs Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.